Drugs / Indigo naturalis

Trials 4

20112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 22 trials
Phase 2 NCT02669888 Oct 2015 → Jan 2017 atopic eczema Chang Gung Memorial Hospital Completed No outcome recorded
Phase 2 NCT02088281 Nov 2012 → Jul 2013 psoriasis Chang Gung Memorial Hospital Completed No outcome recorded
Phase 2/31 trial
Phase 2/3 NCT01445886 Jan 2011 → Jun 2012 psoriasis Yin-ku Lin Completed No outcome recorded
Phase 41 trial
Phase 4 NCT07665294 Oct 2026 → Jun 2027 expected ulcerative colitis Ryan C Ungaro Not yet recruiting No outcome recorded
Comparator or background therapy2 trials
Phase 1 NCT02442960 Comparator Dec 2014 → Jul 2017 ulcerative colitis Stanford University Completed No outcome recorded
Phase 2 NCT01901705 Comparator Feb 2013 → Jan 2014 psoriasis China Medical University Hospital Completed No outcome recorded

Evidence & citations 5 cited values

Every value below carries the sentence it was read from. 7 sources stand behind the page.

FieldValueCited text
Known as Indigo Naturalis “BACKGROUND: Indigo naturalis (IN) is an herbal medicine that has been used for ulcerative colitis with an unclear mechanism of action.” PMID 34969665 ↗ Dec 2021
4

NCT01445886 ↗

NCT02088281 ↗

NCT01901705 ↗

NCT02669888 ↗

Known as QingDai “Capsule doses 235mg - 385mg curcumin/150mg-300mg QingDai” NCT07665294 ↗
Action Inhibit “the therapeutic effect of indigo naturalis in psoriasis may involve inhibiting the activation of Th1 and Th17 cells” NCT02088281 ↗
Modality Traditional medicine (herbal / TCM) “A Chinese Herb, Indigo Naturalis, Extracted in Oil (Lindioil) Used Topically to Treat Psoriatic Nails: A Randomized Clinical Trial.” PMID 25738921 ↗ Jun 2015
Route Topical “The participants applied indigo naturalis extract in oil topically to one of two bilaterally symmetrical psoriatic finger nails twice daily for 24 weeks.” NCT01445886 ↗